•
Sep 30, 2024

Cigna Q3 2024 Earnings Report

The Cigna Group reported strong results for Q3 2024, driven by focused execution across Evernorth Health Services and Cigna Healthcare.

Key Takeaways

The Cigna Group reported a 30% increase in total revenues, reaching $63.7 billion. Adjusted income from operations increased by 5% to $2.1 billion, driven by strong contributions from Evernorth Health Services. The company reaffirmed its 2024 adjusted EPS outlook of at least $28.40.

Total revenues for Q3 2024 increased 30% to $63.7 billion.

Shareholders’ net income for Q3 2024 was $0.7 billion, or $2.63 per share.

Adjusted income from operations for Q3 2024 was $2.1 billion, or $7.51 per share.

The company reaffirms its 2024 outlook for adjusted income from operations of at least $28.40 per share.

Total Revenue
$63.7B
Previous year: $49.1B
+29.8%
EPS
$7.51
Previous year: $6.77
+10.9%
Gross Profit
$54.2B
0
Cash and Equivalents
$5.89B
Previous year: $8.5B
-30.7%
Free Cash Flow
-$353M
Total Assets
$153B
Previous year: $150B
+2.3%

Cigna

Cigna

Forward Guidance

The Cigna Group’s outlook for full year 2024 consolidated adjusted income from operations is at least $28.40 per share. This outlook includes the impact of expected future share repurchases and anticipated 2024 dividends.

Positive Outlook

  • Adjusted Income from Operations, per share at least $28.40
  • Evernorth Adjusted Income from Operations, Pre-Tax at least $7,000 million
  • Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4,775 million
  • Cigna Healthcare Medical Care Ratio 81.7% to 82.5%
  • Includes the impact of expected future share repurchases and anticipated 2024 dividends.

Challenges Ahead

  • Actual results may differ materially depending on a number of factors.
  • Management does not assume any obligation to update these estimates.
  • The Company’s outlook excludes the potential effects of any other business combinations that may occur after the date of this earnings release.
  • The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
  • The program may be suspended or discontinued at any time.